ArriVent Biopharma Launches with Up To $150M in Series A Financing and Strategic Licensing Agreement for Clinical-Stage Oncology Asset

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/2UXlFPB
via IFTTT